Papers by Mathew Maurer
12 results
- Cardiology and Therapy
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
Cohort study of 1,924 peopleInterventions - Circulation Heart Failure
Proteomics Profiling Reveals Molecular Subtypes of Transthyretin Cardiac Amyloidosis
Study in peopleInterventions - Journal of the American College of Cardiology
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B
Trial in peopleInterventions
- Journal of the American College of Cardiology
Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis
Trial in peopleInterventions - JACC Advances
Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study
Cohort study of 154,299 peopleAcute coronary syndrome - JAMA
Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy
Cohort study of 44,123 peopleBiomarkers - AHA Scientific Sessions 2025 Abstract
Left Atrial Reservoir Strain and Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights from the HELIOS-B Trial on Vutrisiran Efficacy
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Comprehensive Plasma Proteomics Profiling Identifies Circulating Biomarkers to Predict Both All-cause Mortality and Disease Progression in Patients with Transthyretin Amyloid Cardiomyopathy
Study in peopleBiomarkers